China Issues Limited Circulation Permit for Antibody Drugs
Friday, 10 December 2021 – 21:03 GMT+7
Illustration of drugs / Credit: Pixabay
Monoclonal antibodies are a type of coronavirus protein that can reduce its ability to enter the body's cells.
The results of clinical trials had shown the efficacy of the drug, which could reduce the risk of patients being hospitalized and dying by about 80 percent, Tsinghua University said in a statement. (ant/dil/mcr20/jpnn)
This news has been broadcast on JPNN.com with the title: Dunia Diteror Omicron, China Luncurkan Obat Penetral Antibodi
China's drug authority issued a limited distribution permit for antibody drugs manufactured by a pharmaceutical institution headquartered in Beijing.
RELATED NEWS
- No More Mask! Indonesia Ease Covid-19 Restrictions Starting Today
- Unud Implements Full Offline Learning as Covid-19 Cases Decline
- News Presenter Ira Koesno's Father Dies Due to Covid-19
- Boeing 737 Carrying 132 People Crashes in China's Forest
- Moderna Booster Vaccine Now Available in Jakarta
- Jonatan Christie Eliminated from German Open, Contracts Covid-19
